EMA Authorised: Dabigatran Etexilate Accord (dabigatran etexilate mesilate) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised the generic dabigatran etexilate mesilate product 'Dabigatran Etexilate Accord' by Accord Healthcare S.L.U. for prevention of venous thromboe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Dabigatran Etexilate Accord (dabigatran etexilate mesilate)

Snippet

Status: Authorised. Therapeutic area: Venous Thromboembolism;Arthroplasty, Replacement. MAH: Accord Healthcare S.L.U.. Decision date: 05/08/2024